Fiona McCartney

716 total citations
22 papers, 561 citations indexed

About

Fiona McCartney is a scholar working on Pharmaceutical Science, Molecular Biology and Nutrition and Dietetics. According to data from OpenAlex, Fiona McCartney has authored 22 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmaceutical Science, 8 papers in Molecular Biology and 4 papers in Nutrition and Dietetics. Recurrent topics in Fiona McCartney's work include Advanced Drug Delivery Systems (17 papers), Drug Solubulity and Delivery Systems (11 papers) and Advancements in Transdermal Drug Delivery (3 papers). Fiona McCartney is often cited by papers focused on Advanced Drug Delivery Systems (17 papers), Drug Solubulity and Delivery Systems (11 papers) and Advancements in Transdermal Drug Delivery (3 papers). Fiona McCartney collaborates with scholars based in Ireland, France and Belgium. Fiona McCartney's co-authors include David J. Brayden, John P. Gleeson, Mónica Rosa, Delyan R. Hristov, Nicolas Ritter, Frédéric Demarne, Vincent Jannin, Sam Maher, Werner Ulrich and Didier Bazile and has published in prestigious journals such as ACS Nano, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Fiona McCartney

21 papers receiving 559 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fiona McCartney Ireland 13 349 207 80 78 49 22 561
Andreas Bernkop‐Schnürch Austria 10 390 1.1× 167 0.8× 126 1.6× 48 0.6× 57 1.2× 12 581
Haijun Zhong China 12 208 0.6× 158 0.8× 114 1.4× 67 0.9× 38 0.8× 25 426
Janine Griesser Austria 11 392 1.1× 190 0.9× 111 1.4× 23 0.3× 45 0.9× 12 583
Felix Prüfert Austria 15 441 1.3× 218 1.1× 160 2.0× 23 0.3× 42 0.9× 19 633
Soheil Haddadzadegan Austria 10 270 0.8× 201 1.0× 159 2.0× 22 0.3× 44 0.9× 15 565
Bao Le‐Vinh Austria 13 222 0.6× 163 0.8× 129 1.6× 24 0.3× 39 0.8× 18 467
Andreas E. Clausen Austria 8 334 1.0× 118 0.6× 112 1.4× 37 0.5× 30 0.6× 10 472
A.B.J. Noach Netherlands 10 260 0.7× 188 0.9× 45 0.6× 68 0.9× 28 0.6× 15 533
Yulian Lin China 12 210 0.6× 347 1.7× 66 0.8× 162 2.1× 13 0.3× 18 673

Countries citing papers authored by Fiona McCartney

Since Specialization
Citations

This map shows the geographic impact of Fiona McCartney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona McCartney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona McCartney more than expected).

Fields of papers citing papers by Fiona McCartney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona McCartney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona McCartney. The network helps show where Fiona McCartney may publish in the future.

Co-authorship network of co-authors of Fiona McCartney

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona McCartney. A scholar is included among the top collaborators of Fiona McCartney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona McCartney. Fiona McCartney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCartney, Fiona. (2025). November Industry News. Therapeutic Delivery. 16(3). 199–204. 1 indexed citations
2.
McCartney, Fiona, et al.. (2025). Solidified ionic liquid-based formulations of metformin with enhanced GI epithelial permeability. International Journal of Pharmaceutics. 678. 125649–125649.
3.
McCartney, Fiona, et al.. (2025). Computational and Experimental Analysis of Drug‐Coated Microneedle Skin Insertion: The Mode of Administration Matters. Advanced Materials Interfaces. 12(17). 1 indexed citations
4.
McCartney, Fiona, Yining Xu, Inês Domingues, et al.. (2024). An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragment to treat inflammatory bowel disease. Journal of Controlled Release. 374. 254–266. 6 indexed citations
5.
McCartney, Fiona, et al.. (2024). LabrafacTM MC60 is an efficacious intestinal permeation enhancer for macromolecules: Comparisons with Labrasol® ALF in ex vivo and in vivo rat studies. International Journal of Pharmaceutics. 661. 124353–124353. 2 indexed citations
6.
Koziolek, Mirko, Patrick Augustijns, Rodrigo Cristofoletti, et al.. (2023). Challenges in Permeability Assessment for Oral Drug Product Development. Pharmaceutics. 15(10). 2397–2397. 12 indexed citations
7.
McCartney, Fiona. (2023). September Industry News Update. Therapeutic Delivery. 14(11). 669–673. 1 indexed citations
8.
Lundquist, Patrik, Zhigao Niu, Lungile Nomcebo Thwala, et al.. (2022). Barriers to the Intestinal Absorption of Four Insulin-Loaded Arginine-Rich Nanoparticles in Human and Rat. ACS Nano. 16(9). 14210–14229. 15 indexed citations
9.
McCartney, Fiona, Diego Romano Perinelli, Mattia Tiboni, et al.. (2021). Permeability-enhancing effects of three laurate-disaccharide monoesters across isolated rat intestinal mucosae. International Journal of Pharmaceutics. 601. 120593–120593. 12 indexed citations
10.
Shrestha, Neha, Yining Xu, Fiona McCartney, et al.. (2021). Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease. Acta Biomaterialia. 140. 561–572. 39 indexed citations
11.
McCartney, Fiona, et al.. (2021). Synthesis and In Vivo Evaluation of Insulin-Loaded Whey Beads as an Oral Peptide Delivery System. Pharmaceutics. 13(5). 656–656. 7 indexed citations
12.
McCartney, Fiona, et al.. (2020). An Enteric-Coated Polyelectrolyte Nanocomplex Delivers Insulin in Rat Intestinal Instillations When Combined with a Permeation Enhancer. Pharmaceutics. 12(3). 259–259. 20 indexed citations
13.
Gleeson, John P. & Fiona McCartney. (2019). Striving Towards the Perfect In Vitro Oral Drug Absorption Model. Trends in Pharmacological Sciences. 40(10). 720–724. 21 indexed citations
14.
McCartney, Fiona, Vincent Jannin, Delyan R. Hristov, et al.. (2019). Labrasol® is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies. Journal of Controlled Release. 310. 115–126. 96 indexed citations
15.
Hristov, Delyan R., Fiona McCartney, Eugene Mahon, et al.. (2019). Silica-Coated Nanoparticles with a Core of Zinc, l-Arginine, and a Peptide Designed for Oral Delivery. ACS Applied Materials & Interfaces. 12(1). 1257–1269. 25 indexed citations
16.
McCartney, Fiona, Mónica Rosa, & David J. Brayden. (2019). Evaluation of Sucrose Laurate as an Intestinal Permeation Enhancer for Macromolecules: Ex Vivo and In Vivo Studies. Pharmaceutics. 11(11). 565–565. 43 indexed citations
17.
McCartney, Fiona, Eric Sultan, Clara V. Álvarez, et al.. (2018). Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin. Journal of Controlled Release. 286. 402–414. 48 indexed citations
18.
Maher, Sam, et al.. (2018). Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae. International Journal of Pharmaceutics. 539(1-2). 11–22. 43 indexed citations
19.
McCartney, Fiona, John P. Gleeson, & David J. Brayden. (2016). Safety concerns over the use of intestinal permeation enhancers: A mini-review. Tissue Barriers. 4(2). e1176822–e1176822. 120 indexed citations
20.
Greiner, Romy, et al.. (2015). Reasons why some irrigation water users fail to comply with water use regulations: A case study from Queensland, Australia. Land Use Policy. 51. 26–40. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026